Liquid chromatography-tandem mass spectrometry applications in endocrinology
- 25 August 2009
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 29 (3) , 480-502
Abstract
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) has been recognized as a primary methodology for the accurate analysis of endogenous steroid hormones in biological samples. This review focuses on the use of LC–MS/MS in clinical laboratories to assist with the diagnosis of diverse groups of endocrine and metabolic diseases. Described analytical methods use on‐line and off‐line sample preparation and analytical derivatization to enhance analytical sensitivity, specificity, and clinical utility. Advantages of LC–MS/MS as an analytical technique include high specificity, possibility to simultaneously measure multiple analytes, and the ability to assess the specificity of the analysis in every sample. All described analytical methods were extensively validated, utilized in routine diagnostic practice, and were applied in a number of clinical and epidemiological studies, including a study of the steroidogenesis in ovarian follicles. © 2009 Wiley Periodicals, Inc. Mass Spec Rev 29:480‐502, 2010Keywords
This publication has 135 references indexed in Scilit:
- Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatizationClinical Biochemistry, 2008
- Ion mobility–mass spectrometryJournal of Mass Spectrometry, 2008
- The use of receiver operating characteristic curves in biomedical informaticsJournal of Biomedical Informatics, 2005
- Simultaneous quantitative analysis of isobars by tandem mass spectrometry from unresolved chromatographic peaksJournal of Mass Spectrometry, 2004
- Liquid Chromatography–Tandem Mass Spectrometry Assay for Simultaneous Measurement of Estradiol and Estrone in Human PlasmaClinical Chemistry, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Coronary Heart Disease Risk Factors in Women With Polycystic Ovary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Androgen and 19-norsteroid profiles in human preovulatory follicles from stimulated cycles: An isotope dilution-mass spectrometric studyThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Steroid 21-hydroxylation by human preovulatory follicles from stimulated cycles: A mass spectrometrical study of deoxycorticosterone, 21-hydroxypregnenolone and 11-deoxycortisol in follicular fluidThe Journal of Steroid Biochemistry and Molecular Biology, 1987